DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 226 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $115,000 | -37.8% | 11,043 | -24.9% | 0.00% | – |
| Q2 2022 | $185,000 | -17.0% | 14,695 | -28.5% | 0.00% | – |
| Q1 2022 | $223,000 | -41.3% | 20,539 | -23.9% | 0.00% | -100.0% |
| Q4 2021 | $380,000 | +219.3% | 26,984 | -1.8% | 0.00% | – |
| Q3 2020 | $119,000 | -52.0% | 27,479 | +37.2% | 0.00% | – |
| Q3 2018 | $248,000 | -69.1% | 20,024 | -61.9% | 0.00% | -100.0% |
| Q2 2018 | $802,000 | +14.9% | 52,563 | +49.4% | 0.00% | 0.0% |
| Q1 2018 | $698,000 | -39.9% | 35,181 | -43.4% | 0.00% | 0.0% |
| Q4 2017 | $1,162,000 | +327.2% | 62,144 | +338.9% | 0.00% | – |
| Q1 2016 | $272,000 | -50.8% | 14,158 | -38.1% | 0.00% | -100.0% |
| Q4 2015 | $553,000 | -5.6% | 22,877 | -4.1% | 0.00% | 0.0% |
| Q3 2015 | $586,000 | +41.2% | 23,867 | +34.7% | 0.00% | 0.0% |
| Q2 2015 | $415,000 | – | 17,719 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital, LLC | 5,791,735 | $85,543,929 | 4.00% |
| Deep Track Capital, LP | 6,756,956 | $99,800,240 | 3.85% |
| Intrinsic Edge Capital Management LLC | 1,133,099 | $16,735,872 | 1.89% |
| Bain Capital Life Sciences Investors, LLC | 915,000 | $13,514,550 | 1.51% |
| Kynam Capital Management, LP | 500,000 | $7,385,000 | 1.21% |
| Rhenman & Partners Asset Management AB | 700,000 | $10,339,000 | 1.12% |
| AlphaCentric Advisors LLC | 110,000 | $1,624,700 | 0.92% |
| HighVista Strategies LLC | 133,000 | $1,964,410 | 0.91% |
| Affinity Asset Advisors, LLC | 200,000 | $2,954,000 | 0.83% |
| Rock Springs Capital Management LP | 1,813,758 | $26,789,206 | 0.72% |